One of the Worst Blue Chip Stocks to Buy
From Yahoo Finance: 2025-05-12 15:05:00
- Merck & Co., Inc. (MRK) is analyzed among the 10 worst blue chip stocks to buy, despite being a leading global healthcare company. The company’s stock is considered undervalued by Bank of America Securities, with strong growth potential and pipeline progress.
- BlackRock reports that international equities outperformed US equities by 11% in 2025, as value stocks gain favor over growth stocks. Active management strategies are seen as advantageous in navigating fluctuating markets.
- Merck & Co., Inc. (MRK) saw a 6% increase in KEYTRUDA sales in Q1 2025, driven by global demand in oncology and vaccines. The company’s focus on emerging therapeutic areas positions it well for future growth.
- While MRK ranks 3rd on the list of worst blue chip stocks to buy, it remains an investment potential according to GreensKeeper Asset Management. However, deeply undervalued AI stocks are seen as offering greater promise for higher returns in a shorter timeframe.
Read more at Yahoo Finance: One of the Worst Blue Chip Stocks to Buy